Emergencies preparedness, response

Yellow fever

African countries endorse the Eliminate Yellow Fever Epidemics (EYE) Strategy

African health ministers meeting in Victoria Falls, Zimbabwe, for the 67th Session of the WHO Regional Committee have agreed on ten priority actions to guide countries on the elimination of the yellow fever epidemics by 2026.

This endorsement reflects the strong political commitment of African nations to controlling yellow fever as a whole region.

Updated yellow fever vaccination recommendations for Brazil

WHO

4 April 2017 - The WHO Secretariat determined that the following areas in the States of Bahia, Rio de Janeiro, and São Paulo should be considered at risk for yellow fever. Vaccination against yellow fever is recommended for international travellers visiting the State of Rio de Janeiro and at risk areas in the states of Bahia and São Paulo.

WHO/PAHO works with Brazilian government in response to yellow fever outbreak

WHO/PAHO

31 March 2016 - WHO/PAHO has provided support to Brazil in responding to the ongoing outbreak of yellow fever. The collaboration ranges from provision of vaccines through the International Coordinating Group for Vaccine Provision (ICG), to dissemination of scientific, evidence-based recommendations. WHO/PAHO teams have been active in several areas, including mosquito control, data analysis and working with patients infected or suspected to be infected with yellow fever.

WHO dispatched 3.5 million doses of yellow fever vaccine for outbreak response in Brazil

WHO/A. Costa
A vaccination campaign against yellow fever is currently ongoing in Brazil

30 March 2017 - In response to the yellow fever outbreak currently on-going in Brazil some 3.5 million doses of vaccine from the emergency stockpile were deployed to the country through the International Coordinating Group (ICG) on Vaccine Provision for yellow fever. The ICG oversees a continuously replenished emergency stockpile of 6 million doses of yellow fever vaccine. The ICG includes four agencies: the World Health Organization (WHO), United Nations Children’s Fund (UNICEF,) the International Federation of Red Cross and Red Crescent Societies (IFRC), and Médicines Sans Frontières (MSF). The Government of Brazil will reimburse the cost of the 3.5 million doses sent through the yellow fever emergency stockpile financed by Gavi Alliance.

Be proactive and protect yourself from yellow fever

WHO/PAHO

People living in or travelling to potentially endemic areas of yellow fever transmission should protect themselves. The yellow fever vaccine provides life-long protection against the disease. You should protect yourself from mosquito bites by wearing light-coloured, long-sleeved shirts and trousers, sleeping under a bed net day and night, using insect repellents and getting rid of stagnant water from places where mosquitoes breed.

Information products on yellow fever and vaccination are available in multiple languages including Portuguese.

Resetting the yellow fever strategy

WHO/E. Soteras Jalil

Changes in the way humans live and work, and the resurgence of mosquito vectors, particularly the Aedes aegypti mosquito (which spreads Zika, dengue fever and chikungunya), have raised the global risk of yellow fever. Two large yellow fever outbreaks in Angola and Democratic Republic of the Congo are now under control but these are just warnings of bigger outbreaks to come if action is not taken.

A coalition of partners working to stop yellow fever outbreaks met in Geneva on 12 September 2016 to develop a new strategy - Eliminating Yellow fever Epidemics (EYE). This strategy aims to protect the populations most at risk, ensure a ready supply of yellow fever vaccine, build resilience in urban centres and prevent international spread.

Yellow fever: Facts and challenges

How is yellow fever transmitted? Is there a vaccine? Why is an urban yellow fever outbreak such a concern? Dr Sylvie Briand, Director of Pandemic and Epidemic Diseases Department at WHO gives answers to these and other questions in this short, informative video.

An updated strategy to Eliminate Yellow fever Epidemics (EYE) has been developed by a coalition of partners (Gavi, UNICEF and WHO) to face yellow fever’s changing epidemiology, resurgence of mosquitoes, and the increased risk of urban outbreaks and international spread. This global, comprehensive long term strategy (2017-2026) targets the most vulnerable countries, while addressing global risk, by building resilience in urban centres, and preparedness in areas with potential for outbreaks and ensuring reliable vaccine supply. Its strategic objectives, built on lessons learned, are:

1) Protect at-risk populations;
2) Prevent international spread;
3) Contain outbreaks rapidly.

Yellow fever is caused by a virus (Flavivirus) which is transmitted to humans by the bites of infected aedes and haemogogus mosquitoes. The mosquitoes either breed around houses (domestic), in forests or jungles (wild), or in both habitats (semi-domestic).

Occasionally, infected travellers from areas where yellow fever occurs have exported cases to countries that are free of yellow fever, but the disease can only spread easily if that country has mosquito species able to transmit it, specific climatic conditions and the animal reservoir needed to maintain it.

Once contracted, the yellow fever virus incubates in the body for 3 to 6 days, followed by infection that can occur in one or two phases. The first, "acute", phase usually causes fever, muscle pain with prominent backache, headache, shivers, loss of appetite, and nausea or vomiting. Most patients improve and their symptoms disappear after 3 to 4 days.

However, 15% of patients enter a second, more toxic phase within 24 hours of the initial remission. High fever returns and several body systems are affected. The patient rapidly develops jaundice and complains of abdominal pain with vomiting. Bleeding can occur from the mouth, nose, eyes or stomach. Once this happens, blood appears in the vomit and faeces. Kidney function deteriorates. Half of the patients who enter the toxic phase die within 10 to 14 days, the rest recover without significant organ damage.

Yellow fever is difficult to diagnose, especially during the early stages. It can be confused with severe malaria, dengue hemorrhagic fever, leptospirosis, viral hepatitis (especially the fulminating forms of hepatitis B and D), other hemorrhagic fevers (Bolivian, Argentine and Venezuelan hemorrhagic fevers as well as other Flaviviridae such as the West Nile and Zika viruses) and other diseases, as well as poisoning.

Blood tests can detect yellow fever antibodies produced in response to the infection. Several other techniques are used to identify the virus in blood specimens or liver tissue collected after death. These tests require highly trained laboratory staff and specialized equipment and materials.

There are three types of transmission cycle:

1. Sylvatic (or jungle): In tropical rainforests, yellow fever occurs in monkeys that pass the virus to mosquitoes that feed on them. The infected mosquitoes bite humans entering the forest resulting in sporadic cases of yellow fever, usually in young men working in the forest (e.g. loggers).

2. Intermediate: In humid or semi-humid parts of Africa, small-scale epidemics occur. Semi-domestic mosquitoes (that breed in the wild and around households) infect both monkeys and people. Increased contact between people and infected mosquitoes leads to transmission. Many separate villages in an area can suffer cases simultaneously. This is the most common type of outbreak in Africa. An outbreak can become a more severe epidemic if the infection is carried into an area populated with both domestic mosquitoes and unvaccinated people.

3. Urban: Large epidemics occur when infected people introduce the virus into a densely populated area with a high number of non-immune people and Aedes mosquitoes. Infected mosquitoes transmit the virus from person to person.

There is no specific treatment for yellow fever, only supportive care to treat dehydration, respiratory failure, and fever. Associated bacterial infections can be treated with antibiotics. Supportive care may improve outcomes for seriously ill patients, but it is rarely available in poorer areas.

Yellow fever can be prevented through vaccination and mosquito control.

The yellow fever vaccine is safe and affordable, and a single dose provides life-long immunity against the disease.

Mosquito control can also help to prevent yellow fever, and is vital in situations where vaccination coverage is low or the vaccine is not immediately available. Mosquito control includes eliminating sites where mosquitoes can breed, and killing adult mosquitoes and larvae by using insecticides in areas with high mosquito density. Community involvement through activities such as cleaning household drains and covering water containers where mosquitoes can breed is a very important and effective way to control mosquitoes.


Technical information

General information

This page links all WHO information on yellow fever in Portuguese.

Subscribe to our newsletter

Contact us

For any request please send us an email to: mediainquiries@who.int

Regional information on yellow fever